Remdesivir Recruiting Phase 3 Trials for Novel Coronavirus Infectious Disease (COVID-19) / COVID - 19 / SARS (Severe Acute Respiratory Syndrome) / COVID Treatment

IndicationsStatusPurposePhase
RecruitingTreatment3
clinicaltrials.gov IdentifierTitleDrugs
NCT04546581Inpatient Treatment With Anti-Coronavirus Immunoglobulin (ITAC)